LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lee, Hwan Hee ^a   Sanada, Satoru ^b   An, Seung Min ^a   Ye, Byeong Jin ^a   Lee, Jun Ho ^a   Seo, Young Kyo ^a   Lee, Changwook ^a   Lee Kwon, Whaseon ^a   Küper, Christoph ^c   Neuhofer, Wolfgang ^d   Choi, Soo Youn ^a   Kwon, Hyug Moo ^a  

^a Ulsan National Institute of Science and Technology   (South Korea)

^b JCHO Sendai Hospital   (Japan)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERULENIN; DNA; E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NFAT5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL; CHLOROCEBUS AETHIOPS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE;

ANIMALS; CERCOPITHECUS AETHIOPS; CERULENIN; DNA; E1A-ASSOCIATED P300 PROTEIN; HUMANS; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; TRANSCRIPTION FACTORS;

EID: 84964838156     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24921     Document Type: Article

References (42)

1. Karin, M. & Lin, A. NF-α B at the crossroads of life and death. Nat. Immunol. 3, 221-227 (2002).
2. Oeckinghaus, A., Hayden, M. S. & Ghosh, S. Crosstalk in NF-α B signaling pathways. Nat. Immunol. 12, 695-708 (2011).
3. Karin, M. & Greten, F. R. NF-α B: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759 (2005).
4. Richmond, A. NF-α B, chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2, 664-674 (2002).
5. Chen, L. F. & Greene, W. C. Shaping the nuclear action of NF-α B. Nat. Rev. Mol. Cell Biol. 5, 392-401 (2004).
6. Wan, F. & Lenardo, M. J. The nuclear signaling of NF-α B: current knowledge, new insights, and future perspectives. Cell Res. 20, 24-33 (2010).
7. Tartey, S. & Takeuchi, O. Chromatin remodeling and transcriptional control in innate immunity: emergence of Akirin2 as a novel player. Biomolecules. 5, 1618-1633 (2015).
8. Gilmore, T. D. & Garbati, M. R. Inhibition of NF-α B signaling as a strategy in disease therapy. Curr. Top Microbiol. Immunol. 349, 245-263 (2011).
9. Okamoto, T. NF-α B and rheumatic diseases. Endocr. Metab. Immune. Disord. Drug Targets. 6, 359-372 (2006).
10. Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nat. Immunol. 12, 204-212 (2011).
11. Miyakawa, H., Woo, S. K., Dahl, S. C., Handler, J. S. & Kwon, H. M. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl Acad. Sci. USA. 96, 2538-2542 (1999).
12. Lopez-Rodriguez, C., Aramburu, J., Rakeman, A. S. & Rao, A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc. Natl. Acad. Sci. USA. 96, 7214-7219 (1999).
13. Aramburu, J. et al. Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5. Biochem. Pharmacol. 72, 1597-1604 (2006).
14. Lee, S. D. et al. TonEBP stimulates multiple cellular pathways for adaptation to hypertonic stress: organic osmolyte-dependent and-independent pathways. Am. J. Physiol Renal. Physiol. 300, F707-715 (2007).
15. Go, W. Y., Liu, X., Roti, M. A., Liu, F. & Ho, S. N. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc. Natl Acad. Sci. USA. 101, 10673-10678 (2004).
16. Buxadé, M. et al. Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5. J. Exp. Med. 209, 379-393 (2012).
17. Kim, N. H. et al. The xanthine oxidase-NFAT5 pathway regulates macrophage activation and TLR-induced inflammatory arthritis. Eur J Immunol. 44, 2721-2736 (2014).
18. Yoon, H. J. et al. NFAT5 is a critical regulator of inflammatory arthritis. Arthritis Rheum. 63, 1843-1852 (2011).
19. Halterman, J. A., Kwon, H. M., Leitinger, N. & Wamhoff, B. R. NFAT5 expression in bone marrow-derived cells enhances atherosclerosis and drives macrophage migration. Front. Physiol. 3, 1-7 (2012).
20. Lawrence, T. & Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 11, 750-761 (2011).
21. Küper, C., Beck, F. X. & Neuhofer, W. Generation of a conditional knockout allele for the NFAT5 gene in mice. Front Physiol. 5, 507 (2015).
22. Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & Förster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 (1999).
23. Buras, J. A., Holzmann, B. & Sitkovsky, M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov. 4, 854-865 (2005).
24. Lee, S. D., Woo, S. K. & Kwon, H. M. Dimerization is required for phosphorylation and DNA binding of TonEBP/NFAT5. Biochem Biophys Res Commun. 294, 967-975 (2002).
25. Lee, S. D., Colla, E., Sheen, M. R., Na, K. Y. & Kwon, H. M. Multiple domains of TonEBP cooperate to stimulate transcription in response to hypertonicity. J Biol Chem. 278, 47571-47577 (2003).
26. Hoberg, J. E., Popko, A. E., Ramsey, C. S. & Mayo, M. W. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol. 26, 457-471 (2006).
27. Shakhov, A. N. et al. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med. 171, 35-47 (1990).
28. Tsai, E. Y. et al. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol. 20, 6084-6094 (2000).
29. Funabashi, H. et al. Binding site of cerulenin in fatty acid synthetase. J Biochem. 105, 751-755 (1989).
30. Gerritsen, M. E. et al. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl Acad. Sci. USA. 94, 2927-2932 (1997).
31. Perkins, N. D. et al. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275, 523-527 (1997).
32. Sadler, A. J. et al. The acetyltransferase HAT1 moderates the NF-α B response by regulating the transcription factor PLZF. Nat Commun. 6, 6795 (2015).
33. Rim, J. S. et al. Transcription of the sodium/myo-inositol cotransporter gene is regulated by multiple tonicity-responsive enhancers spread over 50 kilobase pairs in the 5'-flanking region. J Biol Chem. 273, 20615-20621 (1998).
34. Miyakawa, H. et al. Cis-And trans-Acting factors regulating transcription of the BGT1 gene in response to hypertonicity. Am J Physiol. 274, F753-761 (1998).
35. Lee, J. H. et al. TonEBP suppresses adipogenesis and insulin sensitivity by blocking epigenetic transition of PPAR? 2. Sci Rep. 5, 10937 (2015).
36. Teferedegne, B., Green, M. R., Guo, Z. & Boss, J. M. Mechanism of action of a distal NF-kappaB-dependent enhancer. Mol Cell Biol. 26, 5759-5770 (2006).
37. Rahman, M. M. & McFadden, G. Modulation of NF-α B signalling by microbial pathogens. Nat Rev Microbiol. 9, 291-306 (2011).
38. Glass, C. K. & Saijo, K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol. 10, 365-376 (2010).
39. Yuan, M. et al. Reversal of obesity-And diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 293, 1673-1677 (2001).
40. Goldfine, A. B. et al. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann Intern Med. 159, 1-12 (2013).
41. Haase, D. et al. Fatty acid synthase as a novel target for meningioma therapy. Neuro Oncol. 12, 844-854 (2010).
42. Kim, J. A., Jeon, U. S., Kwon, M. S., Lim, S. W. & Kwon, H. M. . Transcriptional activator TonE-binding protein in cellular protection and differentiation. Methods Enzymol. 428, 253-267 (2007).